ストックスクリーナーアプリを入手
198.69
1.95%
3.8762
前日終値:
$194.81
開ける：
$198.02
24時間の取引高:
2,204
Relative Volume:
0.27
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.94%
1か月 パフォーマンス:
+2.06%
6か月 パフォーマンス:
+27.58%
1年 パフォーマンス:
+23.56%
1日の値動き範囲:
$198.00
$199.06
1週間の範囲:
$187.38
$199.06
52週間の値動き範囲:
$135.34
$199.06
Vaneck Biotech Etf Stock (BBH) Company Profile
BBH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
199.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.69 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.39 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.44 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
266.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
624.21 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf (BBH) 最新ニュース
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
VanEck ETF TrustVanEck Biotech ETF announces Annual dividend, payable on December 26, 2025 - marketscreener.com
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
AI In Pharma And Biotech: Market Trends 2025 And Beyond - Seeking Alpha
China – Lockdowns, Growth, Policy Options - VanEck
Sentiment Swings and Fundamentals - VanEck
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
Diversify Your Portfolio: These 5 AI ETFs Could Surge 200% by 2030 - Nasdaq
Rates and Consequences - VanEck
Gold Responds and Reminds in March - VanEck
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Uncover Big Opportunities in Smaller Companies - VanEck
The Future of Fandom: Why Esports and Gaming Are Outpacing Traditional Sports - VanEck
Investing in Semiconductor ETFs & Stocks - VanEck
SMH ETF: Question & Answer - VanEck
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH - Defense World
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
VanEck Mid-November 2025 Bitcoin ChainCheck - VanEck
Top Blockchain Companies to Watch Leading into 2026 - VanEck
Three Factors Driving Bitcoin’s Price - VanEck
VanEck Vectors Biotech ETF (BBHus) Stock Price Quote Today & Current Price Chart - Capital.com
A Potential Valuation Methodology for Ethereum - VanEck
VanEck Europe: Celebrating 30 Billion USD in AUM, 70 Years of Innovation, and 10 Years Listed on Deutsche Börse - VanEck
Big Pharma rally as FDA picks new drug regulator (LLY:NYSE) - Seeking Alpha
Rare Earths in the Spotlight as US and China Battle Over Supply - VanEck
Gold in 2025: A New Era of Structural Strength and Enduring Appeal - VanEck
Vaneck Biotech Etf (BBH) 財務データ
Vaneck Biotech Etf (BBH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.59%
0.41%
大文字化:
|
ボリューム (24 時間):